LIVE VENTURES Inc financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data LIVE VENTURES Inc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	79	152	200	193	192	273	287	355	473	445
Cost of revenue	59	89.5	125	122	116	174	189	240	328	299
Gross profit	20	62.6	74.2	70.9	75.3	99.5	97.8	116	145	146
Selling and marketing	9.11	8.27	14.1	14.8	11.3	11.4	12.5	13.4	22.4	17.3
General and administrative	8.54	36.2	49.3	52.8	43.6	52.2	54.5	86.7	118	114
Operating expenses	17.7	44.5	63.4	67.6	54.9	63.7	71.9	100	158	131
Operating income	2.32	18.1	10.8	3.26	20.4	35.8	25.9	15.4	-13.6	14.6
Interest expense	4.02	7.6	8.64	6.32	5.25	5.21	4.21	12.7	16.8	15.6
Other non-operating income	0.07	-7.52	-0.47	-8.89	-4.81	3.89	5.69	-14	-17.7	13.8
Pre-tax income	2.39	10.6	10.3	-5.64	15.6	39.7	31.6	1.47	-31.3	28.4
Income tax	-15.6	4.08	4.41	-1.63	4.96	8.66	6.88	1.57	-4.66	5.66
Net income to minority interests	0.12	0		0	-0.27	-0.18	0
Net income	17.8	6.5	5.92	-4.01	10.9	31.2	24.7	-0.1	-26.7	22.7
EBITDA	5.44	23.1	16.8	8.93	26.3	42.6	33.1	29.7	3.57	31.9
EPS, basic	6.33	2.94	3.01	-2.11	6.40	19.92	7.94	-0.03	-8.48	7.35
EPS, diluted	5.40	1.61	1.58	-2.11	3.09	9.80	7.84	-0.03	-8.48	4.93
Shares, basic (weighted)	2.82	2.21	1.97	1.9	1.71	1.57	3.12	3.13	3.15	3.09
Shares, diluted (weighted)	3.3	4.05	3.74	1.9	3.53	3.18	3.16	3.13	3.15	4.62
Dividend per share			0.00	0.00	0.00	0.00	0.00

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	0.77	3.97	1.99	2.68	8.98	4.66	4.6	4.31	4.6	8.83
Receivables	7.6	10.6	13.3	11.9	20.1	21.6	25.7	41.2	46.9	39.9
Inventory	11.1	34.5	46.4	39.2	64.5	70.7	97.7	131	126	121
Other current assets	5.79	6.44	3.31	1.69	1.78	1.64	2.48	4.92	4.12	3.57
Total current assets	25.2	55.5	66	55.8	95.9	98.8	135	183	182	173
Property, plant and equipment	14	22.8	28	22.6	31.7	35.6	64.6	80.7	82.9	77.5
Lease right-of-use assets					29.5	30.5	33.7	54.5	55.7	53.1
Goodwill	0	36.9	36.9	36.9	37.8	41.5	41.1	75.9	61.2	61.2
Intangible assets	1.69	4.21	6.67	2.2	1.06	4.7	3.84	26.6	25.1	20.1
Total assets	53.5	129	141	122	197	212	279	422	408	386
Accounts payable	5.4	8.22	14.6	14.1	9.12	10.6	10.9	27.2	31	27.4
Accrued liabilities	6.4	8.99	8.57	13	14.8	17	16.5	31.8	31.7	31.8
Deferred revenue	0		0.35
Short-term debt	2.01	48.9	14	7.9	12	16.1	18.9
Total current liabilities	13.8	66.4	37.5	35	57.4	65	56.4	97.8	130	111
Long-term debt			58.8	47.8	63.4	37.6	59.7
Lease liabilities					28.1	27	30.4	48.2	50.1	46.4
Other non-current liabilities			0.58	0.65	0.73	0	1.62	4.1	6.66	3.95
Total liabilities	29.3	95	102	88.3	154	137	181	322	335	291
Total debt	13.5	26.6	58.8	55.7	75.4	53.6	78.6
Paid-in capital	59.6	63.2	63.7	63.9	64.5	65.3	65.3	69.4	69.7	75.8
Retained earnings	-35.1	-28.6	-23.3	-27.4	-16.4	14.8	39.5	39	12.3	29.1
Treasury stock	-0.3	-1	-1.55	-2.44	-4.1	-4.52	-7.22	-8.21	-9.07	-9.6
Shareholders' equity	24.2	32.9	39.4	34.1	43.9	75.5	97.6	100	72.9	95.3
Minority interests	0				-0.27	-0.45	-0.45	0
Total equity	24.2	32.9	38.8	34.1	43.7	75.1	97.2	100	72.9	95.3
Total liabilities and equity	53.5	129	141	122	197	212	279	422	408	386
Shares outstanding	2.79	1.99	1.95	1.83	1.59	1.58	3.07	3.16	3.13	3.07

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	18	6.5	5.92	-4.01	10.7	31	24.7	-0.1	-26.7	22.7
Depreciation and amortization	3.13	5.03	6.05	5.67	5.86	6.79	7.17	14.3	17.2	17.3
Stock-based compensation	0.26	0.2	0.5	0.14	0.09	0.49	0.04	0.45	0.33	0.2
Deferred income tax	-15.7	3.52	4.18	-1.86	4.07	3.82	6.02	-2.85	-6.88	2.89
Change in receivables	-0.14	-2.86	-1.16	1.99	-0.95	-1.58	-1.13	0.79	-1.5	7.22
Change in inventory	1.58	-3.81	-4.95	7.16	12.3	-8.49	-20.2	-9.54	4.55	5.2
Change in payables	-0.13	-2.34	4.98	-0.44	9.39	2.77	-2.38	0.56	1.79	-2.96
Cash from operations	7.88	7.87	11.8	19.1	28.8	29.2	6.4	26	20.6	28.7
Capital expenditures	-3.19	-6.41	-8.71	-2.38	-3.88	-10.8	-12.1	-10	-8.47	-7.69
Acquisitions	0	-47.4	0				-24.8	0
Cash from investing	-2.54	-53.7	-9.39	0.1	-8.78	-17.4	-40	-63.9	-21.5	-7.69
Stock issued	0				0	0.32	0
Share buybacks	-0.3	-0.7	-0.55	-0.89	-1.66	-0.42	-2.7	-0.99	-0.87	-0.53
Dividends paid	-0	-0	0
Cash from financing	-7.3	49.1	-4.41	-19.2	-13.7	-16.1	33.6	37.6	1.16	-16.7
Net change in cash	-1.96	3.2	-1.98	-0.06	6.3	-4.32	-0.06	-0.29	0.29	4.23
Free cash flow	4.69	1.46	3.11	16.7	24.9	18.4	-5.73	16	12.1	21
Interest paid	1.25	5.33	7.89	5.81	4.45	4.34	3.96	7.8	14	14.9
Income taxes paid	0.47	-0.15	0.76	0.04	0.03	1.54	6.15	0.38	-0.02	2.14

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $7.50 on November 11, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	33.1%	Gross profit / revenue.
Operating margin	2.4%	Operating income / revenue.
EBITDA margin	6.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-0.9%	Pre-tax income / revenue.
Net margin	-0.6%	Net income / revenue.
FCF margin	3.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	4.9%	Cash from operations / revenue.
Return on equity (ROE)	-2.8%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-0.7%	Net income / average total assets.
Return on invested capital (ROIC)	10.2%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.7%	Capital expenditures / revenue.
D&A / revenue	3.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-5.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	15.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	18.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	0.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	14.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	14.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 3y	-17.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-6.4%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	793.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-1.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	4.0%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 3y	-2.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	15.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS CAGR, 3y	-14.3%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	9.8%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	39.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	64.8%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-0.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	72.8%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-3.4%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	30.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-0.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	16.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-5.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	11.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	14.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	46.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	13.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	5.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.35x	Current assets / current liabilities.
Quick ratio	0.39x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.08x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	76.2%	Total liabilities / total assets.
Interest coverage	0.71x	Operating income / interest expense.
Working capital	$45.5M	Current assets - current liabilities.
Goodwill and intangibles / assets	19.0%	(Goodwill + intangible assets) / total assets.
Tangible book value	$18.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.13x	Revenue / average total assets.
Fixed asset turnover	5.79x	Revenue / average property, plant and equipment.
Inventory turnover	2.42x	Cost of revenue / average inventory.
Days inventory	151 days	365 x average inventory / cost of revenue.
Receivables turnover	10.9x	Revenue / average receivables.
Days sales outstanding	33 days	365 x average receivables / revenue.
Days payables	32 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	152 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	34.9%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.84	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$141.37	Revenue / diluted weighted shares.
FCF per share	$4.54	Free cash flow / diluted weighted shares.
Operating cash flow per share	$6.97	Cash from operations / diluted weighted shares.
Book value per share	$29.91	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$6.00	Tangible book value / shares outstanding.
Cash per share	$3.55	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	0.0%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$23.0M	Share price x shares outstanding.
Enterprise value	$12.1M	Market cap + total debt - cash - short-term investments.
P/S	0.05x	Market cap / revenue.
P/B	0.25x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.25x	Market cap / tangible book value, when positive.
P/FCF	1.65x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	1.08x	Market cap / cash from operations, when positive.
EV/Sales	0.03x	Enterprise value / revenue.
EV/EBIT	1.16x	Enterprise value / operating income, when both are positive.
EV/EBITDA	0.47x	Enterprise value / EBITDA, when both are positive.
EV/FCF	0.87x	Enterprise value / free cash flow, when both are positive.
FCF yield	60.5%	Free cash flow / market cap.
Earnings yield	-11.2%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.0%	(Dividends paid + share buybacks) / market cap.

What was LIVE VENTURES Inc's revenue in fiscal 2025?

LIVE VENTURES Inc reported revenue of $444.9M for fiscal 2025, 5.9% lower than the year before.

Was LIVE VENTURES Inc profitable in fiscal 2025?

Yes. Net income was $22.7M, a net margin of 5.1%.

How much free cash flow did LIVE VENTURES Inc generate in fiscal 2025?

Cash from operations of $28.7M minus capital expenditures of $7.7M left free cash flow of $21.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to LIVE VENTURES Inc